The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.
  | Costanza, B., Umelo, I., Bellier, J., Turtoi, A., & Castronovo, V. (2017). Stromal Modulators of TGF-β in Cancer. Journal of Clinical Medicine. doi:10.3390/jcm6010007  Peer Reviewed verified by ORBi |
 | Umelo, I., Noeparast, A., Chen, G., Renard, M., Geers, C., Vansteenkiste, J., Giron, P., De Wever, O., Teugels, E., & De Greve, J. (January 2016). Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer. Oncotarget, 7 (3), 3068-83. doi:10.18632/oncotarget.6585 Peer Reviewed verified by ORBi |
 | Umelo, I., De Wever, O., Kronenberger, P., Van Deun, J., Noor, A., Singh, K., Teugels, E., Chen, G., Bracke, M., & De Greve, J. (2015). Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade. Oncotarget, 6 (24), 20132-44. doi:10.18632/oncotarget.3853 Peer Reviewed verified by ORBi |
 | Umelo, I., Wever, O. D., Kronenberger, P., Noor, A., Teugels, E., Chen, G., Bracke, M., & Greve, J. D. (2015). Combined inhibition of rho-associated protein kinase and EGFR suppresses the invasive phenotype in EGFR-dependent lung cancer cells. Lung Cancer, 90 (2), 167-74. doi:10.1016/j.lungcan.2015.08.008 Peer Reviewed verified by ORBi |
 | Chen, G., Noor, A., Kronenberger, P., Teugels, E., Umelo, I., & De Greve, J. (2013). Synergistic effect of afatinib with su11274 in non-small cell lung cancer cells resistant to gefitinib or erlotinib. PLoS ONE, 8 (3), 59708. doi:10.1371/journal.pone.0059708 Peer Reviewed verified by ORBi |
 | Chen, G., Kronenberger, P., Teugels, E., Umelo, I., & De Greve, J. (2013). Effect of siRNAs targeting the EGFR T790M mutation in a non-small cell lung cancer cell line resistant to EGFR tyrosine kinase inhibitors and combination with various agents. Biochemical and Biophysical Research Communications, 431 (3), 623-9. doi:10.1016/j.bbrc.2012.12.070 Peer reviewed |
 | Chen, G., Umelo, I., Lv, S., Teugels, E., Fostier, K., Kronenberger, P., Dewaele, A., Sadones, J., Geers, C., & De Greve, J. (2013). miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PLoS ONE, 8 (3), 60317. doi:10.1371/journal.pone.0060317 Peer Reviewed verified by ORBi |
 | Chen, G., Kronenberger, P., Teugels, E., Umelo, I., & De Greve, J. (2012). Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab. BMC Medicine, 10, 28. doi:10.1186/1741-7015-10-28 Peer Reviewed verified by ORBi |
 | De Greve, J., Teugels, E., Geers, C., Decoster, L., Galdermans, D., De Mey, J., Everaert, H., Umelo, I., In't Veld, P., & Schallier, D. (2012). Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu. Lung Cancer, 76 (1), 123-7. doi:10.1016/j.lungcan.2012.01.008 Peer Reviewed verified by ORBi |
 | Chen, G., Kronenberger, P., Umelo, I., Teugels, E., & De Greve, J. (2010). Quantification of epidermal growth factor receptor T790M mutant transcripts in lung cancer cells by real-time reverse transcriptase-quantitative polymerase chain reaction. Analytical Biochemistry, 398 (2), 266-8. doi:10.1016/j.ab.2009.11.034 Peer Reviewed verified by ORBi |
